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Abstract
Plasminogen binding proteins have been described both for Gram positive and Gram negative bacteria. In the present
work we describe the purification and characterization of a plasminogen binding protein from Haemophilus influenzae
 .strain HI-23459 . Bacteria were sonicated in order to solubilize plasminogen-binding proteins. The supernatant was
subjected to affinity chromatography on plasminogen kringle-4 fragment bound to Sepharose 4B and subsequently
processed by ion-exchange chromatography on DEAE-Sepharose CL-6B. Characterization of the protein by SDS-PAGE
displayed a single band with a molecular mass of about 55 000, both prior to and after reduction. The purified protein
 .stimulates tPA tissue plasminogen activator catalysed plasminogen activation by a factor of approximately 300, mainly
due to a decrease in K . Antibodies were raised in rabbits and used in quantitative and qualitative analysis. However, usingm
a FITC-conjugate we failed to demonstrate the presence of the purified protein on the surface of intact bacteria. The
corresponding gene was isolated from a l EMBL3 phage library prepared from chromosomal DNA from the same H.
influenzae strain, using an oligonucleotide probe based on the NH -terminal amino acid sequence. An open reading frame2
corresponding to 472 amino acid was found. The amino acid sequence of the translated gene demonstrates 97% identity
 .with the recently published sequence from aspartate ammonia lyase aspartase from H. influenzae. Enzymatic analysis of
the purified protein revealed a high aspartase activity.
 .Keywords: Plasminogen; Plasminogen activation; Aspartase; H. influenzae
1. Introduction
During the last decade it has been found that many
somatic cells of different origin have the property to
w xspecifically bind plasminogen 1 . This binding is
believed to be mediated through specific structures,
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which have been called receptors, although their
physiological function is far from understood. A few
years ago, our group was able to identify specific
binding of plasminogen to many different types of
bacteria, including both Gram-positive and Gram-
w xnegative species 2–6 , following the initial observa-
tion by Lottenberg et al. of plasmin-binding to a
w xstrain of Streptococcus pyogenes 7,8 . Plasminogen
binds to several bacterial species with high affinity
and the dissociation constants, K , have been esti-d
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mated as about 20–200 nM. The interactions are in
most cases abolished by 6-aminohexanoic acid 6-
.AHA , suggesting that the lysine-binding sites in the
plasminogen molecule are involved in the binding.
All strains of H. influenzae which have been
investigated so far, have displayed this kind of prop-
erty. In the present work we describe the purification
and functional characterization of a plasminogen-
binding protein from H. influenzae strain HI-23459.
The corresponding gene was cloned and sequenced in
both strands. The effect of the purified protein on the
activation of plasminogen by urokinase or tPA was
also studied.
2. Materials and methods
2.1. Reagents
CNBr-activated Sepharose 4B and DEAE-Sep-
harose CL-6B were purchased from Pharmacia AB
 .Uppsala, Sweden . Acrylamide, sodium dodecyl-
 .sulfate SDS , 4-chloro-1-naphthol and nitrocellulose
 .sheets were from BioRad Richmond, CA, USA .
 w.Aprotinin Trasylol was from Bayer AG Lev-
 .erkusen Germany . Haemin and BHI broth was from
 . wDifco Laboratories Detroit, MI, USA . Isovitalex
was from Becton Dickinson Microbiology System
 .Cockeysville, MD, USA . Flavigen-pli and tPA
 .  .lyophilised were from Biopool Umea, Sweden .˚
 w.Urokinase Ukidan was from Laboratories Sereno
 .Aubonne, Switzerland . The chromogenic substrate
 .D-Val-Leu-Lys-pNA S-2251 was from Chro-
 .mogenix Molndal, Sweden . All other chemicals¨
were of analytical grade and most of them were from
 .Merck Darmstadt, Germany .
2.2. Plasminogen and a -antiplasmin2
w xPlasminogen was purified from human plasma 9 ,
and plasminogen fragments was obtained from plas-
w xminogen as described elsewhere 10 . Kringle-4 from
plasminogen was insolubilized on CNBr-activated
Sepharose 4B as recommended by the manufacturer.
About 5 mg of kringle-4 was bound per ml of settled
gel. Plasmin was obtained from purified plasminogen
and a -antiplasmin was purified from human plasma2
w xas described elsewhere 11 .
2.3. Determination of protein concentration
The protein concentration was determined accord-
w xing to the method of Lowry 12 using bovine serum
 .albumin BSA as a standard.
2.4. Purification of plasminogen-binding proteins
w xThe H. influenzae strain HI-23459 3 was culti-
vated over night in BHI broth, supplemented with 20
w mgrl Haemin and 1% Isovitalex . Bacteria about 4
.l of culture was centrifuged, washed twice and sus-
pended to a bacterial concentration of 2 P 1011
 . w xcellsrml typically about 100 ml 13 . Subsequently,
the bacterial suspension was sonicated for 3=4 min
at 08C, using a Sonifer cell disruptor B-30 Branson,
.Switzerland and thereafter centrifuged for 40 min at
48C and 33 000=g. After addition of aprotinin final
.concentration 500 KIUrml the supernatant was
stored frozen at y708C until processed further.
Prior to the affinity chromatography on plasmino-
gen kringle-4-Sepharose, NaCl was added to the su-
 . pernatant final concentration 0.5 M . The column 5
2 .cm =5 cm was equilibrated with 0.05 M sodium
phosphate buffer, pH 7.0, containing 0.5 M NaCl, 0.1
grl Tween-80 and 5 units aprotininrml. The super-
natant was applied to the column and the washing
was continued with the equilibration buffer until A280
-0.1. In order to remove NaCl the column was
further washed with 0.05 M sodium phosphate buffer,
pH 7.0, containing 0.1 grl Tween-80 and 5 units
aprotininrml. Elution was carried out by 0.01 M
6-AHA in the phosphate buffer.
The eluted material from the affinity column was
dialysed against 0.12 M sodium phosphate buffer, pH
7.3, containing 0.1 grl Tween-80. The material was
subsequently subjected to ion exchange chromatogra-
 2phy on a DEAE-Sepharose CL-6B column 2.0 cm
.=5 cm . Elution was performed with a linear gradi-
ent 0–0.3 M NaCl in 0.12 M phosphate buffer. The
chromatograms were monitored by the absorbance at
280 nm. Screening for plasminogen-binding protein
was also performed, using the slot-blot method as
described. After getting a specific antiserum towards
the 55 000 M plasminogen-binding protein, the chro-r
matograms were also routinely screened by elec-
troimmunoassay.
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2.5. Dodecylsulfate polyacrylamide gel electrophore-
( )sis SDS-PAGE
SDS-PAGE was performed by an established pro-
w xcedure 14 . The gels were stained with Commassie
Brilliant Blue.
2.6. Immunochemical Analyses
Rabbit antiserum was produced by immunization
of rabbits with the purified plasminogen-binding pro-
 .tein about 200 mg in Freunds complete adjuvant .
Booster doses with the same amount in Freunds
incomplete adjuvant were given every third month.
Double diffusion was performed in order to demon-
strate that antisera were specific. Electroimmunoas-
w xsay was performed according to Laurell 15 .
2.7. Semiquantitati˝e method for estimation of plas-
minogen-binding capacity
 .Each sample 200 ml was applied to a nitrocellu-
lose membrane, using a Bio-Dot SF apparatus for
 .Protein Slot Blotting Bio Rad . Subsequently it was
treated with 100 mgrl dried milk dissolved in 0.01
M Tris-HCl, pH 7.3, containing 0.15 M NaCl. The
membrane was incubated with a plasminogen solu-
tion 50 mgrl in 0.1 M sodium phosphate buffer, pH
.7.3 for 1 h. Thereafter positive spots were detected
w xwith the aid of HRP-conjugated 16 goat anti-plas-
minogen IgG, properly diluted in the Tris-HCl buffer
as above, but also containing 1 grl BSA. After
washing the membrane with the Tris-HCl buffer,
w xperoxidase activity was visualized 17 .
2.8. NH -terminal amino acid sequence analysis2
w xNH -terminal amino acid sequence analysis 182
was performed in a pulsed liquid phase sequencer
model 477A, Applied Biosystems, Foster City, CA,
.USA equipped with an on-line PTH 120 analyser.
2.9. Effect of the purified plasminogen binding pro-
tein on the acti˝ation of plasminogen
Activation of plasminogen in the presence or ab-
sence of plasminogen-binding protein was performed
utilizing a coupled enzymatic system. Plasminogen
 . 24 nM–13.2 mM , plasmin substrate flavigen-pli,
.  .0.4 mM , plasminogen activators tPA or urokinase
and plasminogen-binding protein in various concen-
 .trations 0–0.22 mgrml were mixed in the wells of
a quartz microtiter plate HELLMA, Baden, Ger-
.many . The buffer used for dilutions was in all
instances 0.1 M sodium phosphate buffer, pH 7.0,
containing 0.1 grl Tween-80. The final concentration
of urokinase was 2 IUrml, whereas in the experi-
ments with tPA the final concentration was 20 IUrml.
The absorbance at 405 nm was measured Anthos
.labtec reader 2001 every 10 min for about 100 min.
When the absorbance at 405 nm was plotted against
time squared almost straight lines were obtained after
 .a short lag phase typically less than 10 min . The
slopes of the curves were taken as a measure of the
plasminogen activation rate.
2.10. Determination of aspartase acti˝ity
Aspartase activity was measured spectrophotomet-
rically at 240 nm by determination of fumarate for-
w xmation 19 . The assay system contained a mixture of
 .  .MgCl 3 mM and sodium L-aspartate 0.1 M in a2
 .Tris-HCl pH 9 buffer and the reaction was initiated
by the addition of the enzyme. The increase in ab-
w xsorbance at 240 nm was determined 20 . Aspartase
activity was expressed in units, one unit being the
amount converting 1.0 mmol of L-aspartase to fu-
marate per min at 308C. The molar extinction coeffi-
cient of fumarate at 240 nm is 2530 My1 =cmy1
w x21 .
2.11. Effect of the purified plasminogen binding pro-
tein on the plasminra -antiplasmin reaction2
The influence of the purified plasminogen-binding
protein on the rate of the reaction between plasmin
and a -antiplasmin was studied by mixing plasmin2
 . final concentration 4.1 nM and a -antiplasmin fi-2
.nal concentration 5.9 nM in the presence of a plas-
min substrate 0.3 mM D-Val-Leu-Lys-pNA in 0.1 M
.sodium phosphate buffer, pH 7.0 . The absorbance at
410 nm was continuously recorded Uvikon 810 Kon-
.tron . The apparent rate constants were calculated
from the classical formula for second-order reactions
using the slopes of the curves at different time inter-
w xvals 22 .
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2.12. Cloning and DNA sequencing
w xDNA was isolated by the method of Marmur 23
from H. influenzae cells which were cultivated and
w xharvested as described earlier 3,13 . A genomic DNA
library was constructed using the bacteriophage l
 .EMBL 3 Stratagene, La Jolla, CA, USA . A mixture
of 256 oligonucleotides, 17 bases long with the se-
quence 5X-G -C -C r T-T-C -Tr C r A r G -G -C -
TrCrArG-G-G-TrCrArG-A-C-GrA-T-C-3X de-
rived from the NH -terminal protein sequence,2
residues 14–19, was used as a hybridization probe
w xboth in Southern blot 24 and plaque hybridization
w xtechniques 25 . The hybridization and washing con-
ditions was essentially as described by Sambrook et
w xal. 26 . A 3.4 kb BamHIrSalI restriction enzyme
fragment hybridizing to the oligonucleotide probe
was isolated from one of the positive l recombinants
and subcloned into the plasmid vector pUC 18. DNA
sequencing of the fragment was performed using the
Taq DyeDeoxye terminator cycle sequencing kit for
the 373 DNA sequencing system from Applied
Biosystems, USA. The sequence was determined in
both strands using the gene walking strategy.
3. Results
3.1. Purification of plasminogen-binding proteins
from H. influenzae strain 23459
Purification of plasminogen-binding proteins from
H. influenzae strain 23459 was performed as outlined
in Section 2. A typical chromatogram of the super-
natant after sonication of bacteria on Sepharose-bound
plasminogen kringle-4 is demonstrated in Fig. 1.
Regularly less than 5% of the total protein by weight
was adsorbed and could be eluted with 0.01 M
6-AHA. The material eluted with 6-AHA was then
subjected to ion exchange chromatography on
DEAE-Sepharose CL-6B. Elution was performed by
a linear gradient 0–0.3 M NaCl. The elution profile is
demonstrated in Fig. 2. Approximately 30% of the
protein passed the column unadsorbed, while one
main peak was obtained at a NaCl concentration of
.about 0.1 M on the gradient elution.
The purification procedure was followed by the
slot-blot method for semiquantitative estimation of
Fig. 1. Affinity chromatography on plasminogen kringle-4-Sep-
harose. The flow rate was 25 mlrh and 2.5 ml fractions were
 .collected. Elution start with 6-AHA is marked by x . The
 .absorbance at 280 nm was recorded ‘ and the concentration of
the 55 000 M plasminogen-binding protein was determined byr
 .electroimmunoassay I .
 .plasminogen-binding proteins see Section 2 . Almost
all plasminogen-binding capacity was adsorbed to the
 .plasminogen kringle-4-Sepharose column Fig. 3 .
Furthermore, more than 80% of the plasminogen-
binding capacity found in the 6-AHA-eluate was
adsorbed on the DEAE-Sepharose column and eluted
by the gradient with NaCl. For this reason we have
concentrated on investigating the properties of the
purified major plasminogen-binding protein found in
this eluate.
SDS-PAGE of the different fractions obtained dur-
ing the purification procedure is demonstrated in Fig.
4. The protein peak eluting at about 0.1 M NaCl in
the DEAE-Sepharose chromatography constitutes a
single band with an apparent molecular mass of about
55 000 both prior to and after reduction. The main
compound in the DEAE-Sepharose break-through
fraction is a protein with a molecular mass of about
25 000. It is contaminated, however, with several low
M compounds.r
The purification procedure was monitored quanti-
tatively using a specific rabbit antiserum. During the
affinity chromatographic step on plasminogen
kringle-4-Sepharose a 30-fold purification is obtained
with a yield of about 50%. After this step the 55 000
M plasminogen-binding protein is more than 50%r
pure. After the final chromatography on DEAE-Seph-
arose the protein is completely purified with a total
yield of about 20%. The results obtained during the
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Fig. 2. Ion exchange chromatography on DEAE-Sepharose CL
6B. Elution was performed with a linear gradient 0–0.3 M NaCl
in the equilibration buffer. The flow rate was 10 mlrh and 1.8 ml
fractions were collected. The absorbance at 280 nm was recorded
 .‘ and the concentration of the 55 000 M plasminogen-bindingr
 .protein was determined by electroimmunoassay I .
purification procedure are summarized in Table 1.
Using a FITC-conjugate of the same antiserum we
however failed to demonstrate the purified protein on
the surface of intact bacteria.
NH -terminal sequencing by automatic Edman2
degradation for 35 steps displayed the following se-
Fig. 3. Results from a typical slot-blot experiment. Samples in
 .dilutions 1r10–1r1000 were applied to a nitrocellulose sheet.
For experimental details, see Section 2. The following samples
 .  .were applied: a starting material; b plasminogen kringle-4-
 .Sepharose ‘break through’; c 6-AHA eluate from this column;
 .  .d DEAE-Sepharose chromatography ‘break through’; e eluate
from DEAE-Sepharose.
 .  .Fig. 4. SDS-PAGE of: a the starting material; b plasminogen
 .kringle 4-Sepharose ‘break through’; c 6-AHA eluate from this
 .  .column; d DEAE-Sepharose ‘break through’; e eluate from
 .DEAE-Sepharose. The samples were run both non-reduced nr
 .and reduced r .
quence: Thr-Gln-Phe-Arg-Lys-Glu-Val-Asp-Leu-
Leu-Gly-Glu-Arg-Asp-Val-Pro-Ala-Glu-Ala-Tyr-
Trp-Gly-Ile-His-Thr-Leu-Arg-Ala-Val-Glu-Asn-Phe-
Asn-Ile-Ser-.
3.2. Effect of the purified plasminogen binding pro-
tein on the kinetics of plasminogen acti˝ation or on
the reaction between plasmin and a -antiplasmin2
The effect of purified plasminogen-binding protein
on plasminogen activation by urokinase or tPA has
been studied in coupled enzymatic systems. Addition
of purified plasminogen-binding protein, in concen-
trations up to 0.22 mgrml, resulted in a considerable,
and concentration dependent, stimulatory effect when
Table 1
Protein distribution among the different fractions obtained during
purification of the plasminogen-binding protein from H. influen-
zae strain HI-23459
Fraction Total PLG-binding Aspartase Specific
 .protein protein mg activity activity
a .  .  .mg U Urmg
Starting material 575 15.8 720"36 1.2
K4-Sepharose 24.9 14.1 375"43 15.1
DEAE-Sepharose 6.0 6.0 123"7 20.5
a  .Specific activity Urmg is based on total protein.
( )I. Sjostrom et al.rBiochimica et Biophysica Acta 1324 1997 182–190¨ ¨ 187
 .tPA was used as activator Fig. 5 . In contrast, only a
minor influence on urokinase mediated acivation was
 .observed data not shown .
The activation of plasminogen by tPA in the ab-
sence or in the presence of the plasminogen-binding
 .protein 0.22 mgrml was studied at different plas-
 .minogen concentrations 24 nM–13.2 mM . Accord-
ing to Lineweaver–Burk plot of the data the reactions
obeyed Michaelis–Menten’s kinetics. Thus, in the
absence of plasminogen binding protein a K ofm
about 40 mM and a V of 0.086 nM plasminrminmax
were found. In the presence of 0.22 mgrml of the
plasminogen binding protein a K of 0.25 mM and am
V of 0.21 nM plasminrmin were found.max
The influence of purified plasminogen-binding
protein on the reaction between plasmin and a -anti-2
plasmin is demonstrated in Table 2. A concentration
dependent effect was observed resulting in a 3.2-fold
 6 y1 y1decrease in rate constant 19P10 M Ps vs 6.0P
6 y1 y1.10 M Ps at the highest concentration of the
purified plasminogen-binding protein studied 0.15
.mgrml .
Fig. 5. Effect with the purified plasminogen binding protein on
the activation of plasminogen by tPA. The experiments were
performed using different concentrations of the plasminogen-bi-
 .  .  .nding protein: % 0 mgrml ’ 0.02 mgrml B 0.08 mgrml
 .v 0.22 mgrml. The plasminogen concentration was 660 nM in
all experiments.
Table 2
The influence of the reaction rate between plasmin and a -anti-2
plasmin in presence of different concentrations of the purified
plasminogen-binding protein
Plasminogen-binding Reaction rate
y1 y1 6 .  .  .protein mgrml M s P10 ns4
0 19"2.5
0.038 10"1.5
0.075 7.0"1.0
0.150 6.0"0.9
3.3. Identification of the gene, transcriptional and
translational signals
The cloning and sequencing of a 3.4 kb DNA
fragment was performed as outlined in Section 2. A
search for coding regions in the sequence was made
using an option in the Staden package for computer-
ized sequence analysis. An open reading frame of
 .1416 nucleotides was identified Fig. 6 . The reading
frame was preceded by a short sequence resembling
the ribosome binding site sequence of Escherichia
w x Xcoli 27 . The 5 - flanking region upstream of the
proposed ribosome binding site shows the presence
of a possible promoter. The sequence TATAAT at
nucleotide number 68 in Fig. 6 show homology to the
y10 region of the consensus sequence of E. coli
w xpromoters 28 . However no similarity could be ob-
served in the y35 region. Aligning the putative
promoter sequence with promoter sequences from
other cloned genes from H. influenzae including the
w xadenylate cyclase 29 and outer membrane protein P
w x1 30 genes also indicate that the y10 region is
conserved whereas the y35 region is not.
3.4. Protein structure and homology
The molecular mass of the predicted protein was
calculated as 51.218. During the course of this work
the entire sequence of the H. influenzae genome was
published. The comparison of our sequence data with
the published sequence of the H. influenzae aspartase
gene revealed 95% identity, at the nucleotide level
and 97% identity on the protein level. Pronounced
identity on the protein level was also found with
aspartases from other bacterial species including E.
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Fig. 6. Nucleotide sequence and the deduced amino acid sequence of the phi gene in H. influenzae strain HI-23459. Possible promoter
 .  .region - - - and ribosome binding site s s s are shown.
 .  .coli 79% , Serratia marcescens 79% and Bacillus
 .subtilis 48% .
3.5. Aspartase acti˝ity
Due to the identification of the translated gene as
aspartase, the aspartase activity was measured in the
different fractions from the purification procedure.
The results obtained are summarized in Table 1. Our
results demonstrate that the plasminogen binding pro-
tein indeed is an aspartase.
4. Discussion
Many cells of different origins with invasive prop-
erties seem to trigger the fibrinolytic enzyme system
using several different mechanisms. Mammalian cells
such as macrophages or many tumour cells produce
 .plasminogen activators tPA or uPA in high concen-
w xtrations 31 . Certain bacteria such as b-haemolytic
Streptococci, Staphylococcus aureus or Yersinia
pestis produce very potent and unique plasminogen
w xactivators of their own 32,33 . For b-haemolytic
Streptococci and Yersinia pestis, production of plas-
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minogen activators seems to be related to virulence
w xand the invasive behaviour of the bacteria 34,35 .
Another mechanism seems to involve lysine-bind-
ing site mediated plasminogen-binding to the cell
w xsurface 36 . Regarding mammalian cells it has been
found that carboxyterminal lysine residues in the
receptor proteins play important roles in the interac-
tions. The binding is typically quite weak with Kd
values above 1 mM. Nevertheless, plasminogen bound
to the surface of such cells seems to be somewhat
more readily activated than free plasminogen. Also,
the formed plasmin, which is still bound to the cell
surface, is to some extent protected against inactiva-
w xtion by a -antiplasmin 36 .2
Recently we have demonstrated specific plasmino-
gen-binding to a large number of bacterial species,
w xboth Gram-positive and Gram-negative 2–6 . In most
cases plasminogen-binding is abolished in the pres-
ence of the lysine analogue 6-AHA, indicating that
also here interactions via the lysine-binding sites in
w xthe plasminogen ‘kringles’ are involved 3,37 . The
affinity between plasminogen and the presumed bac-
terial ‘receptor proteins’ seems to be much higher
than for the corresponding proteins on mammalian
cells, with dissociation constants, around 20–200 nM
w x2–6 .
In the present work we have purified a plasmino-
gen-binding protein from a strain of H. influenzae
and cloned the corresponding gene. The purification
was monitored by the use of specific rabbit antibod-
ies enabling us to follow the purification procedure.
The concentration of the purified protein in the start-
ing material was almost 5% of the total protein
content in the supernatant obtained after sonication of
bacteria suggesting an important function. Sequence
analysis identified the translated gene as aspartase
which could also be verified by the demonstration of
aspartase activity.
The identification of a plasminogen binding pro-
tein of H. influenzae as an enzyme is in agreement
with the results with other plasminogen binding struc-
tures. Both plasmin binding of group A streptococci
w x w x8 and plasminogen binding of human cells 36 are
mediated by membrane oriented metabolic enzymes.
In all three cases the receptor molecule contains a
C-terminal lysine residue that seems to be important
for its plasminogenrplasmin binding function.
The purified 55 000 M plasminogen-binding pro-r
tein is a potent stimulator of the tPA- but not of the
urokinase-catalysed plasminogen activation, mainly
through an about 200-fold decrease in K . Thism
tPA-mediated plasminogen activation has also been
w xfound in experiments with whole bacteria 38 . Thus,
the stimulation of plasminogen activation is much
higher than what is achieved when plasminogen binds
to mammalian cells. In fact, the data are quite similar
to results obtained with the tPA mediated plasmino-
w xgen activation using fibrin as a stimulator 39,40 .
The data obtained suggest that plasminogen bound to
plasminogen-binding protein through a lysine-binding
site mediated interaction is more easily activated by
tPA. The plasmin formed in this way, with some of
its lysine-binding sites occupied, is in addition some-
what protected against the action of a -antiplasmin.2
This mechanism would provide the bacteria with a
proteolytic tool, which might be of importance in
bacterial invasion.
Using our specific antibodies we failed to detect
the protein on the bacterial surface. This might imply
that the protein is not exposed on the bacterial sur-
face. Another possible explanation could be that our
antibodies mainly recognise unexposed epitopes and
that only a small region of the protein is exposed
externally. The possible secretion of this protein has
not been ruled out. However, the high cellular con-
centration of the protein will result in release of large
amounts during bacterial lysis. Considering the im-
pact of the protein in augmentation of fibrinolytic
activity it could also this way play a role in bacterial
virulence.
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